Latest News

  • 29.6.2018

    A reliable business partner

    Pharmatory has again been ranked as a company with lowest credit risk classification by Dun & Bradstreet.

    Read more

  • 13.3.2018

    Vipuvoimaa EU:lta -hanke alkanut

    Read more

  • 24.11.2017

    Pharmatory and Fermion sign collaboration agreement

    Fermion and Pharmatory have recently signed formal collaboration agreement to provide CDMO services for customers’ API development projects from preclinical to commercial stages. Our complementary service packages enable a seamless project transfer from early development and small scale manufacturing to further optimization and scale-up together with commercial production. Fermion is a fully owned subsidiary of …

    Read more

  • 23.10.2017

    New skills at your disposal

    Mr. Niko Saari joined the Pharmatory team of chemistry experts in October 2017. Niko graduated from the University of Oulu in 2016 and his M.Sc. thesis in synthetic organic chemistry was titled ’Mono- and regioselectivity in Suzuki-Miyaura cross-coupling reactions.’ He is eager to put his skills and enthusiasm into practise to help our customers achieve …

    Read more

  • 23.10.2017

    BioPharm America 2017 in Boston

    Pharmatory participated BioPharm America in Boston 26.-27.9.2017. We thorougly enjoyed both the partnering meetings and the many informal discussions during the breaks and socializing time. Many thanks again to everyone involved and let’s keep on building further on the foundation laid in Boston!

    Read more

Archive